Civic AI
Procurement intelligence
Federal contract award
PERFORMING FDA 510K ENABLING STUDIES FOR A DIAGNOSTIC TO DETECT CIPROFLOXICIN RESISTANCE OR SUSCEPTABILITY
MRIGLOBAL · Department of Health and Human Services
- Value
- $1,571,051
- Start
- May 4, 2026
- End
- Mar 10, 2027
- Action date
- May 11, 2026
- PIID
- 75N93026F00003
- Status
- active
- NAICS
- 541714 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
- Place of performance
- KANSAS CITY, MO
- Award type
- DELIVERY ORDER
Description
PERFORMING FDA 510K ENABLING STUDIES FOR A DIAGNOSTIC TO DETECT CIPROFLOXICIN RESISTANCE OR SUSCEPTABILITY
Need modifications, related awards, and vendor peers? Open the full award workspace.